CAS 851916-42-2

MK-0812 Succinate

CAS : 851916-42-2

MK-0812 Succinate is an effective and selective CCR2 antagonist.

Formule : C₂₈H₄₀F₃N₃O₇

Degré de pureté : 98.62% - 99.93%

Couleur et forme : Solid

Masse moléculaire : 587.63

Ref: TM-T16091

MK-0812 Succinate

CAS : 851916-42-2

MK-0812 Succinate

Degré de pureté : ≥98%

Masse moléculaire : 587.63g/mol

Ref: 54-BUP00298

MK-0812 succinate

CAS : 851916-42-2

MK-0812 succinate is a synthetic pharmaceutical compound, which is a product of chemical synthesis with high purity standards suitable for therapeutic use. This compound is synthesized from raw chemical materials using controlled reactions to ensure specific molecular characteristics and potency. MK-0812 succinate functions by inhibiting specific biological pathways that are implicated in disease progression, primarily by binding to target proteins and altering their function. This action results in modulation of cellular processes that contribute to the pathophysiology of certain diseases.

Formule : C₂₄H₃₄F₃N₃O₃•C₄H₆O₄

Degré de pureté : Min. 95%

Masse moléculaire : 587.63 g/mol

Ref: 3D-BM183631